MARKET

NUVA

NUVA

NuVasive
NASDAQ

Real-time Quotes | Nasdaq Last Sale

54.77
+0.04
+0.07%
After Hours: 54.77 0 0.00% 16:44 07/13 EDT
OPEN
55.37
PREV CLOSE
54.73
HIGH
56.86
LOW
53.95
VOLUME
639.95K
TURNOVER
--
52 WEEK HIGH
81.91
52 WEEK LOW
28.55
MARKET CAP
2.81B
P/E (TTM)
48.12
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 18 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average NUVA stock price target is 67.19 with a high estimate of 85.00 and a low estimate of 55.00.

EPS

NUVA News

More
Needham Upgrades NuVasive to Buy, Announces $74 Price Target
Needham analyst Mike Matson upgrades NuVasive (NASDAQ:NUVA) from Hold to Buy and announces $74 price target.
Benzinga · 06/23 10:28
NuVasive Launches Reline 3D for Pediatric Patients Globally
Zacks · 06/22 16:08
Here's Why You Should Hold on to NuVasive (NUVA) Stock Now
Zacks · 06/22 14:24
NuVasive Expands Complex Spine Portfolio with Global Launch of Reline 3D for Pediatric Deformity
PR Newswire · 06/18 13:33
Edited Transcript of NUVA earnings conference call or presentation 6-May-20 8:30pm GMT
Thomson Reuters StreetEvents · 06/15 23:01
Nuvasive Shows Improved Relative Price Performance; Still Shy Of Benchmark
Investor's Business Daily · 06/15 22:40
NuVasive, Inc. (NUVA): Hedge Funds Taking Some Chips Off The Table
In this article you are going to find out whether hedge funds think NuVasive, Inc. (NASDAQ:NUVA) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been sever
Insider Monkey · 06/15 19:05
NuVasive (NUVA) Up 6.6% Since Last Earnings Report: Can It Continue?
Zacks · 06/05 16:31

Industry

Medical Equipment, Supplies & Distribution
-0.70%
Healthcare Equipment & Supplies
-0.73%

Hot Stocks

Symbol
Price
%Change

About NUVA

Nuvasive, Inc. is a medical device company. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine surgery. Its product portfolio focuses on applications for spine fusion surgery, including biologics used to aid in the spinal fusion process. Its principal product offering includes a minimally-disruptive surgical platform called Maximum Access Surgery (MAS). The platform includes its software-driven nerve detection and avoidance systems, including NVM5, and intraoperative monitoring services and support; MaXcess, an integrated split-blade retractor system, and a range of implants and biologics. The platform combines three product categories: its MaXcess retractors, specialized implants and fixation products, and nerve monitoring systems and service offerings that collectively enable surgeons to detect and navigate around nerves, while directing customized access to the spine for implant delivery.
More

Webull offers kinds of NuVasive, Inc. stock information, including NASDAQ:NUVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NUVA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NUVA stock methods without spending real money on the virtual paper trading platform.